{"id":2419,"date":"2026-04-10T08:28:00","date_gmt":"2026-04-10T05:28:00","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/lipaz-mayi-2\/"},"modified":"2026-04-21T12:38:44","modified_gmt":"2026-04-21T09:38:44","slug":"lipaz-mayi","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/lipaz-mayi\/","title":{"rendered":"Lipaz, Mayi"},"content":{"rendered":"<h1>Lipaz, Mayi<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO6008<\/li>\n<li><strong>Eski Kod:<\/strong> B\u01301281<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<h2>Lipaz, Mayi Testi Nedir?<\/h2>\n<p>Lipaz, Mayi, laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman serum \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>Lipaz, trigliseritleri ya\u011f asitleri ve gliserole par\u00e7alayan bir enzimdir. A\u011f\u0131rl\u0131kl\u0131 olarak pankreasta \u00fcretilir; az miktarda mide, ba\u011f\u0131rsak, dil ve karaci\u011ferde de bulunur. Akut pankreatit tan\u0131s\u0131nda amilazdan daha spesifik ve daha uzun s\u00fcre y\u00fcksek kalan bir belirte\u00e7tir.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>Lipaz, Mayi Hangi Durumlarda \u0130stenir?<\/h2>\n<p>Lipaz, Mayi testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Akut pankreatit tan\u0131s\u0131 (en g\u00fcvenilir biyokimyasal belirte\u00e7)<\/li>\n<li>Kronik pankreatit de\u011ferlendirmesi<\/li>\n<li>Kar\u0131n a\u011fr\u0131s\u0131n\u0131n ay\u0131r\u0131c\u0131 tan\u0131s\u0131<\/li>\n<li>ERCP sonras\u0131 pankreatit takibi<\/li>\n<li>Pankreas hastal\u0131klar\u0131n\u0131n izlenmesi<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Lipaz, Mayi Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>8\u201312 saatlik a\u00e7l\u0131k \u00f6nerilir.<\/li>\n<li>Alkol t\u00fcketimi testten \u00f6nce kesilmelidir.<\/li>\n<li>Kullan\u0131lan ila\u00e7lar hekime bildirilmelidir (opioidler, tiazid di\u00fcretikler).<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Lipaz, Mayi Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>Lipaz, Mayi testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<ul>\n<li><strong>Numune tipi:<\/strong> Ven\u00f6z kan (serum)<\/li>\n<li><strong>Numune al\u0131m\u0131:<\/strong> Koldan ven\u00f6z kan al\u0131n\u0131r.<\/li>\n<li><strong>Y\u00f6ntem:<\/strong> Enzimatik kolorimetrik y\u00f6ntem<\/li>\n<li><strong>Sonu\u00e7 s\u00fcresi:<\/strong> Genellikle ayn\u0131 g\u00fcn; acil durumlarda 1\u20132 saat i\u00e7inde sonu\u00e7lan\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>Lipaz, Mayi Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ayn\u0131 g\u00fcn 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>De\u011fer Aral\u0131\u011f\u0131<\/th><\/tr><\/thead><tbody><tr><td>Yeti\u015fkin<\/td><td>0\u2013160 U\/L<\/td><\/tr><tr><td>\u00c7ocuk<\/td><td>Yeti\u015fkin de\u011ferlerine benzer<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>> Not: Akut pankreatitte tan\u0131sal e\u015fik genellikle normalin \u00fcst s\u0131n\u0131r\u0131n\u0131n 3 kat\u0131d\u0131r (>480 U\/L).<\/p>\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>Lipaz, Mayi Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>Y\u00fcksek Lipaz<\/h3>\n<p><strong>Pankreas kaynakl\u0131 (en s\u0131k):<\/strong><\/p>\n<ul>\n<li>Akut pankreatit (genellikle >3 kat y\u00fckseklik; tan\u0131sal)<\/li>\n<li>Kronik pankreatit alevlenmesi<\/li>\n<li>Pankreas ps\u00f6dokisti<\/li>\n<li>Pankreas t\u00fcm\u00f6r\u00fc<\/li>\n<li>ERCP sonras\u0131 pankreatit<\/li>\n<li>Pankreas kanal\u0131 t\u0131kan\u0131kl\u0131\u011f\u0131<\/li>\n<\/ul>\n<p><strong>Pankreas d\u0131\u015f\u0131 nedenler:<\/strong><\/p>\n<ul>\n<li>B\u00f6brek yetmezli\u011fi (at\u0131l\u0131m azalmas\u0131 \u2014 en s\u0131k pankreas d\u0131\u015f\u0131 neden)<\/li>\n<li>Ba\u011f\u0131rsak obstr\u00fcksiyonu veya perforasyonu<\/li>\n<li>Safra kesesi hastal\u0131klar\u0131 (kolesistit, koledokolitiyazis)<\/li>\n<li>Peptik \u00fclser perforasyonu<\/li>\n<li>Opioid kullan\u0131m\u0131 (Oddi sfinkteri spazm\u0131)<\/li>\n<li>Diyabetik ketoasidoz<\/li>\n<\/ul>\n<h3>Lipaz\u0131n Zamanlamas\u0131 (Akut Pankreatit)<\/h3>\n<ul>\n<li>Semptom ba\u015flang\u0131c\u0131ndan 4\u20138 saat sonra y\u00fckselmeye ba\u015flar<\/li>\n<li>24 saatte pik yapar<\/li>\n<li>8\u201314 g\u00fcn y\u00fcksek kal\u0131r (amilazdan \u00e7ok daha uzun)<\/li>\n<\/ul>\n<h3>Amilaz vs. Lipaz Kar\u015f\u0131la\u015ft\u0131rmas\u0131<\/h3>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>\u00d6zellik<\/th><th>Amilaz<\/th><th>Lipaz<\/th><\/tr><\/thead><tbody><tr><td>Spesifiklik<\/td><td>D\u00fc\u015f\u00fck<\/td><td>Y\u00fcksek<\/td><\/tr><tr><td>Y\u00fckselme s\u00fcresi<\/td><td>6\u201312 saat<\/td><td>4\u20138 saat<\/td><\/tr><tr><td>Pik zaman\u0131<\/td><td>24\u201348 saat<\/td><td>24 saat<\/td><\/tr><tr><td>Normale d\u00f6n\u00fc\u015f<\/td><td>3\u20135 g\u00fcn<\/td><td>8\u201314 g\u00fcn<\/td><\/tr><tr><td>Pankreas d\u0131\u015f\u0131 y\u00fckseklik<\/td><td>S\u0131k<\/td><td>Nadir<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<h3>D\u00fc\u015f\u00fck Lipaz<\/h3>\n<ul>\n<li>Kronik pankreatit (ileri evre \u2014 pankreas dokusu y\u0131k\u0131m\u0131)<\/li>\n<li>Kistik fibrozis<\/li>\n<li>Pankreas yetmezli\u011fi<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>Lipaz, pankreatit tan\u0131s\u0131nda tek ba\u015f\u0131na en g\u00fcvenilir enzimdir; g\u00fcncel k\u0131lavuzlar lipaz\u0131 tercih eder.<\/li>\n<li>Lipaz d\u00fczeyi pankreatit \u015fiddetini yans\u0131tmaz; \u015fiddet de\u011ferlendirmesi klinik ve g\u00f6r\u00fcnt\u00fcleme ile yap\u0131l\u0131r.<\/li>\n<li>B\u00f6brek yetmezli\u011fi olan hastalarda lipaz kronik olarak y\u00fcksek olabilir; bu durum pankreatit ile kar\u0131\u015ft\u0131r\u0131lmamal\u0131d\u0131r.<\/li>\n<li>Hipertrigliseridemiye ba\u011fl\u0131 pankreatitte amilaz d\u00fc\u015f\u00fck kalabilirken lipaz genellikle y\u00fckselir.<\/li>\n<li>Akut pankreatit tan\u0131s\u0131 i\u00e7in lipaz >3 \u00d7 \u00fcst s\u0131n\u0131r, tipik kar\u0131n a\u011fr\u0131s\u0131 veya g\u00f6r\u00fcnt\u00fclemede pankreatit bulgular\u0131ndan en az ikisinin varl\u0131\u011f\u0131 gerekir (revize Atlanta kriterleri).<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Lipaz, Mayi Laboratuvar Bilgileri Yeni Kod: BIO6008 Eski Kod: B\u01301281 Kategori: Biyokimya Numune T\u00fcr\u00fc: Serum Numune Kab\u0131: Sar\u0131 Kapak \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ayn\u0131 g\u00fcn 18:00 Lipaz, Mayi Testi Nedir? Lipaz, Mayi, laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO6008","numune_turu":"Serum","numune_kabi":"Sar\u0131 Kapak","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ayn\u0131 g\u00fcn 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-2419","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=2419"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2419\/revisions"}],"predecessor-version":[{"id":8971,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2419\/revisions\/8971"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=2419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}